{"altmetric_id":4650500,"counts":{"readers":{"mendeley":54,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:597793"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4ea3cf058f6100024ec","authors":["Kelem Kassahun,*,\u2021"],"doi":"10.1021\/tx000180q","endpage":"70","first_seen_on":"2015-10-20T11:11:44+00:00","issns":["0893-228X","1520-5010"],"issue":"1","journal":"Chemical Research in Toxicology","last_mentioned_on":1445339481,"links":["http:\/\/dx.doi.org\/10.1021\/tx000180q"],"pubdate":"2001-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Inorganic Chemistry","scheme":"era"},{"name":"Medicinal And Biomolecular Chemistry","scheme":"era"},{"name":"Organic Chemistry","scheme":"era"}],"scopus_subjects":["Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"startpage":"62","title":"Studies on the Metabolism of Troglitazone to Reactive Intermediates in Vitro and in Vivo. Evidence for Novel Biotransformation Pathways Involving Quinone Methide Formation and Thiazolidinedione Ring Scission\u2020","type":"article","volume":"14","mendeley_url":"http:\/\/www.mendeley.com\/research\/studies-metabolism-troglitazone-reactive-intermediates-vitro-vivo-evidence-novel-biotransformation-p"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":6348733,"mean":5.9808086398984,"rank":1437519,"this_scored_higher_than_pct":67,"this_scored_higher_than":4280553,"rank_type":"exact","sample_size":6348733,"percentile":67},"similar_age_3m":{"total_number_of_other_articles":197701,"mean":10.343891117855,"rank":60256,"this_scored_higher_than_pct":68,"this_scored_higher_than":134549,"rank_type":"exact","sample_size":197701,"percentile":68},"this_journal":{"total_number_of_other_articles":637,"mean":5.0040786163522,"rank":154,"this_scored_higher_than_pct":60,"this_scored_higher_than":384,"rank_type":"exact","sample_size":637,"percentile":60},"similar_age_this_journal_3m":{"total_number_of_other_articles":12,"mean":1.0454545454545,"rank":1,"this_scored_higher_than_pct":91,"this_scored_higher_than":11,"rank_type":"exact","sample_size":12,"percentile":91}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":2,"Researcher":16,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":13,"Student  > Postgraduate":2,"Student  > Master":5,"Other":5,"Student  > Bachelor":1,"Lecturer":1,"Lecturer > Senior Lecturer":1,"Professor":5},"by_discipline":{"Engineering":2,"Medicine and Dentistry":6,"Chemistry":12,"Agricultural and Biological Sciences":20,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":6,"Mathematics":1,"Unspecified":2,"Pharmacology, Toxicology and Pharmaceutical Science":4}}},"geo":{"mendeley":{"US":1,"JP":2,"GB":3}}},"posts":{"wikipedia":[{"title":"Troglitazone","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=686642526#altmetric_citation_e0b3c03c-6685-4952-92e4-a2ade14aa4dc","license":"public","citation_ids":[4650500],"posted_on":"2015-10-20T11:11:21+00:00","summary":"Troglitazone is a ligand to both PPAR\u03b1 and \u2013 more strongly \u2013 PPAR\u03b3. Troglitazone also contains an \u03b1-tocopheroyl moiety, potentially giving it vitamin E-like activity in addition to its PPAR activation.","page_url":"http:\/\/en.wikipedia.org\/?curid=597793","wiki_lang":"en","author":{"name":"Vaibhavadixit","url":"http:\/\/en.wikipedia.org\/wiki\/User:Vaibhavadixit"}}]}}